Xcout IntelAlpha-9 Oncology
Alpha-9 Oncology Inc. is a clinical-stage radiotherapeutic company developing targeted, next-generation radiopharmaceuticals for cancer therapy with operations spanning Boston, Massachusetts and Vancouver, Canada.
Subscribe to see Alpha-9 Oncology’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alpha-9 Oncology at a glance
Alpha-9 Oncology is a biotech company headquartered in United States. Xcout recorded 9 job postings from Alpha-9 Oncology in the last 90 days.
Hiring at Alpha-9 Oncology
Xcout recorded 9 job postings from Alpha-9 Oncology in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alpha-9 Oncology's hiring signals →
Tech stack
Alpha-9 Oncology competitors
A few of Alpha-9 Oncology's closest competitors — see the full list of competitors and alternatives →
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Actithera, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on delivering targeted radioligand cancer therapies.
Mariana Oncology is a fully integrated radiopharmaceutical company headquartered in Watertown, Massachusetts, that develops precision radioligand therapies to transform cancer treatment.
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
ARTBIO is a biotechnology company developing targeted alpha-particle radioligand therapies for cancer, including treatments intended to selectively deliver radioactive payloads to tumor cells. Its work is aimed at serving oncology patients and healthcare providers treating solid tumors.
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Get Alpha-9 Oncology's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Alpha-9 Oncology? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Alpha-9 Oncology in Xcout Intel
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access